121 related articles for article (PubMed ID: 33378022)
21. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
[TBL] [Abstract][Full Text] [Related]
22. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer.
Jiang K; Xie LF; Xiao TZ; Qiu MY; Wang WL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8861-8869. PubMed ID: 31696473
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137.
Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
Cui D; Qian R; Li Y
Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of lncRNA DANCR functions as an oncogenic role in non-small lung cancer by regulating miR-214-5p/CIZ1 axis.
Chen YR; Wu YS; Wang WS; Zhang JS; Wu QG
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2539-2547. PubMed ID: 32196604
[TBL] [Abstract][Full Text] [Related]
26. LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP.
Weng L; Qiu K; Gao W; Shi C; Shu F
BMC Pulm Med; 2020 Aug; 20(1):213. PubMed ID: 32787827
[TBL] [Abstract][Full Text] [Related]
27. MiR-940 inhibits the progression of NSCLC by targeting FAM83F.
Gu GM; Zhan YY; Abuduwaili K; Wang XL; Li XQ; Zhu HG; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5964-5971. PubMed ID: 30280778
[TBL] [Abstract][Full Text] [Related]
28. MAGI1-IT1 stimulates proliferation in non-small cell lung cancer by upregulating AKT1 as a ceRNA.
Zhang G; Chen HX; Yang SN; Zhao J
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):691-698. PubMed ID: 32016970
[TBL] [Abstract][Full Text] [Related]
29. LncRNA H19 serves as a ceRNA and participates in non-small cell lung cancer development by regulating microRNA-107.
Qian B; Wang DM; Gu XS; Zhou K; Wu J; Zhang CY; He XY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5946-5953. PubMed ID: 30280776
[TBL] [Abstract][Full Text] [Related]
30. LINC00632 inhibits the malignant development of non-small cell lung cancer by downregulating miR-1203.
Luo T; Yan L; Liu H
J BUON; 2020; 25(3):1517-1524. PubMed ID: 32862599
[TBL] [Abstract][Full Text] [Related]
31. Study on molecular mechanism of MiRNA-29a in promoting proliferation and invasion of non-small-cell lung cancer by inhibiting MTSS1.
Liu M; Zeng X; Lu YX; Mo YJ; Liao TH; Gan C; Lu XQ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5531-5538. PubMed ID: 30229825
[TBL] [Abstract][Full Text] [Related]
32. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
Xia LH; Yan QH; Sun QD; Gao YP
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827
[TBL] [Abstract][Full Text] [Related]
33. MiR-451a suppressed cell migration and invasion in non-small cell lung cancer through targeting ATF2.
Shen YY; Cui JY; Yuan J; Wang X
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5554-5561. PubMed ID: 30229828
[TBL] [Abstract][Full Text] [Related]
34. MiR-572 promotes the development of non-small cell lung cancer by targeting KLF2.
Sun B; Zhao J; Shao ZY
Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3083-3090. PubMed ID: 35587058
[TBL] [Abstract][Full Text] [Related]
35. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
[TBL] [Abstract][Full Text] [Related]
36. MiR-296-3p may affect the proliferation and migration of non-small cell lung cancer cells via regulating RABL3.
Ge T; Wu HC; Zhou YY; Shen SM; Zhu LG; You GX
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5823-5830. PubMed ID: 31298353
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
Zhang MY; Lin J; Kui YC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
[TBL] [Abstract][Full Text] [Related]
38. MiRNA-300 suppresses proliferation, migration and invasion of non-small cell lung cancer via targeting ETS1.
Yang YB; Tan H; Wang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10827-10834. PubMed ID: 31858551
[TBL] [Abstract][Full Text] [Related]
39. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
Zhao M; Ma W; Ma C
Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
Pang L; Cheng Y; Zou S; Song J
Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
